Related Experiment Video
Updated: Jun 1, 2026

Measurement of BK-polyomavirus Non-Coding Control Region Driven Transcriptional Activity Via Flow Cytometry
Published on: July 13, 2019
Progressive multifocal leukoencephalopathy (PML) development is associated with mutations in JC virus capsid protein
Leonid Gorelik1, Carl Reid, Manuela Testa
1Biogen IDEC Inc., Cambridge, MA, USA. leonid.gorelik@biogenidec.com
Abstract:
Progressive multifocal leukoencephalopathy (PML), a fatal demyelinating disease caused by JC virus (JCV) infection of oligodendrocytes, may develop in patients with immune disorders following reactivation of chronic benign infection. Mutations of JCV capsid viral protein 1 (VP1), the capsid protein involved in binding to sialic acid cell receptors, might favor PML onset. Cerebrospinal fluid sequences from 37/40 PML patients contained one of several JCV VP1 amino acid mutations, which were also present in paired plasma but not urine sequences despite the same viral genetic background. VP1-derived virus-like particles (VLPs) carrying these mutations lost hemagglutination ability, showed different ganglioside specificity, and abolished binding to different peripheral cell types compared with wild-type VLPs. However, mutants still bound brain-derived cells, and binding was not affected by sialic acid removal by neuraminidase. JCV VP1 substitutions are acquired intrapatient and might favor JCV brain invasion through abrogation of sialic acid binding with peripheral cells, while maintaining sialic acid-independent binding with brain cells.
Insights
Mutations in the JC virus (JCV) VP1 protein may cause progressive multifocal leukoencephalopathy (PML) by altering viral binding. These VP1 mutations allow JCV to invade the brain while evading immune detection.
Area of Science:
- Neurovirology
- Molecular Biology
- Immunology
Background:
- Progressive multifocal leukoencephalopathy (PML) is a fatal demyelinating disease caused by JC virus (JCV) infection of oligodendrocytes.
- PML often occurs in immunocompromised individuals due to reactivation of a latent JCV infection.
Purpose of the Study:
- To investigate the role of mutations in the JCV capsid viral protein 1 (VP1) in the pathogenesis of PML.
- To understand how VP1 mutations affect JCV binding to host cells and influence brain invasion.
Main Methods:
- Analysis of JCV VP1 sequences from cerebrospinal fluid, plasma, and urine of PML patients.
- Production and characterization of VP1-derived virus-like particles (VLPs) with specific mutations.
- Assessment of VLP binding to different cell types and their interaction with sialic acid.
Main Results:
- JC virus (JCV) VP1 mutations were identified in the cerebrospinal fluid of most PML patients, correlating with disease onset.
- Mutated VP1-derived VLPs exhibited altered hemagglutination and ganglioside specificity.
- Mutant VLPs showed reduced binding to peripheral cells but retained binding to brain-derived cells, independent of sialic acid.
Conclusions:
- JC virus (JCV) VP1 substitutions are acquired intrapatient and are associated with PML.
- These mutations may facilitate JCV brain invasion by abrogating sialic acid binding to peripheral cells while maintaining sialic acid-independent binding to brain cells.
Related Concept Videos
Encephalitis ll: Pathophysiology
Cytomegalovirus Disease
Arboviral Encephalitis
Encephalitis l: Introduction
Inhibitors of Virion Maturation and Assembly
Viral Mutations

